(0.09%) 5 522.00 points
(0.13%) 39 896 points
(0.18%) 19 787 points
(-0.05%) $81.59
(0.68%) $2.83
(-0.23%) $2 339.00
(0.10%) $29.56
(0.47%) $1 006.50
(0.05%) $0.932
(-0.11%) $10.52
(0.01%) $0.788
(-0.84%) $87.26
-1.77% CHF 3.05
Live Chart Being Loaded With Signals
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 174 066 |
Średni wolumen | 1.89M |
Kapitalizacja rynkowa | 4.21M |
EPS | CHF-12.91 ( Q2 | 2023-06-30 ) |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E |
-2.05 (Sector) 42.63 (Industry) 24.32 |
ATR14 | CHF0.243 (7.98%) |
Wolumen Korelacja
Auris Medical Holding Ltd Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
CBLI | 0.813 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Auris Medical Holding Ltd Korelacja - Waluta/Towar
Auris Medical Holding Ltd Finanse
Annual | 2023 |
Przychody: | CHF0 |
Zysk brutto: | CHF0 (0.00 %) |
EPS: | CHF-14.80 |
FY | 2023 |
Przychody: | CHF0 |
Zysk brutto: | CHF0 (0.00 %) |
EPS: | CHF-14.80 |
FY | 2022 |
Przychody: | CHF305 616 |
Zysk brutto: | CHF-1.14M (-372.44 %) |
EPS: | CHF-29.13 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Auris Medical Holding Ltd
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 11 full-time employees. The firm focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). The betahistine program is in Phase 1 of clinical trials. Other programs in the Company's product pipeline include brimapitide-based AM-111 for the treatment of acute inner ear hearing loss and eskatemine-based Keyzilen (AM-101) for the treatment of acute inner ear tinnitus, both in Phase 3 of clinical trials, as well as AM-102 indicated for tinnitus, undergoing preclinical studies focused on selecting the lead compound. The firm operates through subsidiaries in Switzerland, Ireland and the United States.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej